How about something meaningful instead of your endless, completely meaningless comparisons?And talking about EPP dominance at cuv is probably a joke. 500 patients corresponds to a penetration of at most 10%. If Wolgen were a good negotiator and not an egocentric, Clinuvel could actually have outstanding and influential market power in this area. He had more than a decade to do it. A missed opportunity that won't come back.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.97 |
Change
0.140(1.09%) |
Mkt cap ! $650.6M | |||
| Open | High | Low | Value | Volume |
| $12.90 | $13.25 | $12.88 | $1.207M | 92.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1171 | $13.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.20 | 259 | 1 |
View Market Depth
| Last trade - 15.59pm 31/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |